Tobramycin in external eye disease: a double-masked study vs. gentamicin

Area of Science:

• Ophthalmology
• Microbiology

Background:

• Superficial external eye diseases, including blepharitis and conjunctivitis, are commonly treated with topical antibiotics.
• Tobramycin and gentamicin are widely used aminoglycoside antibiotics for ocular infections.

Purpose of the Study:

• To compare the efficacy and safety of tobramycin versus gentamicin ophthalmic ointments.
• To evaluate the clinical outcomes and antibacterial effectiveness in treating bacterial external eye infections.

Main Methods:

• A double-masked, randomized, multi-center study.
• Involved 77 patients with blepharitis and/or conjunctivitis; 56 qualified for efficacy assessment.
• A 10-day treatment regimen was followed.

Main Results:

• Clinical cure or improvement rates were 97% for tobramycin and 91.3% for gentamicin.
• Tobramycin eradicated or controlled 87.8% of bacterial infections, compared to 77.4% for gentamicin.
• Adverse reaction rates were 9.3% for tobramycin and 17.6% for gentamicin, with all reactions being mild.

Conclusions:

• Tobramycin is a clinically effective and safe topical antibiotic for bacterial external eye infections.
• Tobramycin is comparable to gentamicin, with a potential for better tolerability.
• While trends favored tobramycin, no statistically significant differences were observed (p <= 0.05).